This is a promising course of treatment that can reduce the amount of the SARS-CoV-2 virus in a person’s system.
Price: $999
Returning customer? Click here to login
Monoclonal antibodies are lab-created proteins that mimic the ones our bodies produce to fight viruses. The antibodies defend the body by blocking Covid-19 viruses from attaching to human cells.
Individuals would not be eligible for this treatment if they are:
Hospitalized for COVID-19
Requiring oxygen therapy due to COVID-19
Allergic to any of the ingredients in the medication
Patients receiving monoclonal antibody therapy will undergo an intravenous infusion.
The infusion itself takes about 20 minutes. Afterwards there is an hour-long period where patients are monitored. The entire process takes 2 hours.
In order to preserve the safety and comfort of our patients, we offer this treatment in a house call setting.
One possible side effect of monoclonal antibody therapy is an allergic reaction. These reactions typically only occur during infusion or soon after, and your care team will closely monitor for any signs of an allergic reaction. However, because an infusion reaction can also be delayed, contact your doctor immediately if you notice any of the following signs of an allergic reaction:
Fever and/or chills
Nausea
Headache
Shortness of breath
Low blood pressure
Wheezing
Swelling of lips, face or throat
Muscle aches
Hives or itchiness
The FDA approved monoclonal antibody therapy for emergency use in November of 2020. Monoclonal Antibody therapy has been tested extensively in a clinical trial setting. 70 percent of patients who took monoclonal antibody therapy supported their immune system, leading to the recovery of Covid-19 symptoms.
The FDA updated the EUA to include patients at high risk of developing severe symptoms who are not fully vaccinated, patients who have not had a substantial response to the vaccine, and patients at high risk of exposure to an individual who tested positive for Covid-19.
No. Monoclonal antibody treatment can be used as a preventative measure if you believe you have been exposed to COVID-19.
Yes. This is the monoclonal antibody treatment that the President received.
How it Works